Continued use of a drug called ecopipam can cut the risk of relapse in half for children battling tics caused by Tourette syndrome (TS).

Ecopipam maintains tic improvement, phase III study shows ...

Forbes contributors publish independent expert analyses and insights. I am a physician and public health researcher This voice experience is generated by AI. Learn more. This voice experience is ...

Two technologies that are based on research by University of Nottingham experts to reduce the severity of tics in people with Tourette syndrome (TS) are closer to patient use after being recommended ...